Enzyre
Series AEnzyre raised €12M in a Series A round in Nov 2022. The company is based in Nijmegen, Netherlands. Investors in the round: Demcon Investment, Dutch Government, i&i Biotech Fund and 3 others. Data as of Nov 2026.
Amount raised
€12M
€12,000,000
Native amount
12,000,000 EUR
Stage
Series A
series a
Investors
6
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €12M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
6 namedDate
Nov 2022
Round type
series a
Amount (EUR)
€12M
Other rounds
same companyRelated news
- Dutch startup Enzyre snaps €12M for empowering haemophilia patients to optimise treatment themselvestechfundingnews.com · 2022-11